Login to Your Account



Vertex, GSK Receive Approval For Flexible HIV Drug Lexiva

By Kim Coghill


Wednesday, October 22, 2003
Vertex Pharmaceuticals Inc. and partner GlaxoSmithKline plc won FDA approval of Lexiva, an HIV protease inhibitor that can be dosed once or twice daily, with or without food and water restrictions. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription